Tag: SAH
Diabetes drugs like Ozempic may help mitigate effects of stroke and...
GLP-1 inhibitors like semaglutide (Ozempic)—commonly prescribed diabetes medications that lower blood sugar levels and often cause weight loss—may be able to mitigate against strokes...
Female sex, disease severity and vasospasm among predictors of post-SAH delayed...
A meta-analysis of more than 4,500 patients, presented recently at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates), has revealed...
Roughly half of all healthy life lost to stroke is caused...
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly...
Understanding brain aneurysms: Prevalence, burden, and empowering patients
In a guest piece for NeuroNews, Arūnė Simanavičienė (Kaunas, Lithuania) and Audrius Širvinskas (Vilnius, Lithuania) highlight the work being done by the Brain Aneurysm...
‘Surprising’ regional variations in subarachnoid haemorrhage care revealed by Finnish study
A study recently published in the journal Neurology investigated whether there are discrepancies in the prognosis of subarachnoid haemorrhage (SAH) patients between the university hospital...
US Brain Aneurysm Foundation announces 2023 research grants
The Brain Aneurysm Foundation (BAF) has announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or...
